New

Lymphoma Treatment Market

2021

Lymphoma Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Treatment Type (Hodgkin Lymphoma, Non-Hodgkin Lymphoma); Treatment Drug (Adcetris, Opdivo, Rituxan/MabThera, Imbruvica, Keytruda, Revlimid, Others) Pharmaceutical, General Healthcare Waste, Others); End-user (Hospitals, Clinics, Diagnostic Laboratories, Pharmaceutical/Research Laboratories)

| Report Code: TIPRE00010490 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Lymphoma Treatment Market 2028 Treatment Type, Treatment Drug, End-user | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Lymphoma is a blood cancer that occurs in infection-fighting cells of the immune system, called lymphocytes. These cells are in the lymph nodes, spleen, thymus, bone marrow, and other parts of the body. Lymphoma is of two types, namely Hodgkin and non-Hodgkin. Hodgkin lymphoma develops in the lymph nodes of the lymphatic system. Non-Hodgkin lymphoma is the common type of lymphoma and develops in related tissues of the lymphatic system and lymph nodes. The common symptoms of lymphoma are swelling of lymph nodes, fever, weight loss, night sweets, anorexia, itching, dyspnea, and fatigue. The standard tests applied for the diagnosis of lymphoma are immunophenotyping, FISH (Fluorescence in Situ Hybridization) testing, and flow cytometry.

MARKET DYNAMICS

The government of different nations such as the U.S. and Europe has amplified their funding in R&D for the development of lymphoma treating drugs, which would further augment the growth of the lymphoma treatments market. However, the high cost of this treatment may also hamper the growth of the lymphoma treatments market. Moreover, the rise in the incidence of lymphoma throughout the globe is expected to drive the market growth.

MARKET SCOPE

The "Lymphoma Treatment Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of lymphoma treatment market with detailed market segmentation by treatment type, and treatment drug. The lymphoma treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in lymphoma treatment market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The lymphoma treatment market is segmented on the basis of treatment type, and treatment drug. Based on treatment type the market is segmented as hodgkin lymphoma and non-hodgkin lymphoma. On the basis of treatment drug, the market is categorized as adcetris, opdivo, rituxan/mabthera, imbruvica, keytruda, revlimid and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the lymphoma treatment market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The lymphoma treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting lymphoma treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the lymphoma treatment market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the lymphoma treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from lymphoma treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for lymphoma treatment in the global market. Below mentioned is the list of few companies engaged in the lymphoma treatment market.

The report also includes the profiles of key players in lymphoma treatment market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.


  •   Boston Scientific Corporation
  •   Imricor Medical Systems, Inc.
  •   LivaNova PLC
  •   Mayo Clinic US
  •   Medtronic plc
  •   MicroPort Scientific Corporation
  •   MRI Interventions, Inc.
  •   Nihon Kohden
  •   SCHILLER AG
  •   St. Jude Medical, Inc.


The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Lymphoma Treatments Market - By Treatment Type
1.3.2 Lymphoma Treatments Market - By Treatment Drug
1.3.3 Lymphoma Treatments Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. LYMPHOMA TREATMENTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. LYMPHOMA TREATMENTS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. LYMPHOMA TREATMENTS MARKET - GLOBAL MARKET ANALYSIS
6.1. LYMPHOMA TREATMENTS - GLOBAL MARKET OVERVIEW
6.2. LYMPHOMA TREATMENTS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. LYMPHOMA TREATMENTS MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT TYPE
7.1. OVERVIEW
7.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS
7.3. HODGKIN LYMPHOMA
7.3.1. Overview
7.3.2. Hodgkin Lymphoma Market Forecast and Analysis
7.4. NON-HODGKIN LYMPHOMA
7.4.1. Overview
7.4.2. Non-Hodgkin Lymphoma Market Forecast and Analysis
8. LYMPHOMA TREATMENTS MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT DRUG
8.1. OVERVIEW
8.2. TREATMENT DRUG MARKET FORECASTS AND ANALYSIS
8.3. ADCETRIS
8.3.1. Overview
8.3.2. Adcetris Market Forecast and Analysis
8.4. OPDIVO
8.4.1. Overview
8.4.2. Opdivo Market Forecast and Analysis
8.5. RITUXAN/MABTHERA
8.5.1. Overview
8.5.2. Rituxan/MabThera Market Forecast and Analysis
8.6. IMBRUVICA
8.6.1. Overview
8.6.2. Imbruvica Market Forecast and Analysis
8.7. KEYTRUDA
8.7.1. Overview
8.7.2. Keytruda Market Forecast and Analysis
8.8. REVLIMID
8.8.1. Overview
8.8.2. Revlimid Market Forecast and Analysis
8.9. OTHERS
8.9.1. Overview
8.9.2. Others Market Forecast and Analysis
9. LYMPHOMA TREATMENTS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Lymphoma Treatments Market Overview
9.1.2 North America Lymphoma Treatments Market Forecasts and Analysis
9.1.3 North America Lymphoma Treatments Market Forecasts and Analysis - By Treatment Type
9.1.4 North America Lymphoma Treatments Market Forecasts and Analysis - By Treatment Drug
9.1.5 North America Lymphoma Treatments Market Forecasts and Analysis - By Countries
9.1.5.1 United States Lymphoma Treatments Market
9.1.5.1.1 United States Lymphoma Treatments Market by Treatment Type
9.1.5.1.2 United States Lymphoma Treatments Market by Treatment Drug
9.1.5.2 Canada Lymphoma Treatments Market
9.1.5.2.1 Canada Lymphoma Treatments Market by Treatment Type
9.1.5.2.2 Canada Lymphoma Treatments Market by Treatment Drug
9.1.5.3 Mexico Lymphoma Treatments Market
9.1.5.3.1 Mexico Lymphoma Treatments Market by Treatment Type
9.1.5.3.2 Mexico Lymphoma Treatments Market by Treatment Drug
9.2. EUROPE
9.2.1 Europe Lymphoma Treatments Market Overview
9.2.2 Europe Lymphoma Treatments Market Forecasts and Analysis
9.2.3 Europe Lymphoma Treatments Market Forecasts and Analysis - By Treatment Type
9.2.4 Europe Lymphoma Treatments Market Forecasts and Analysis - By Treatment Drug
9.2.5 Europe Lymphoma Treatments Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Lymphoma Treatments Market
9.2.5.1.1 Germany Lymphoma Treatments Market by Treatment Type
9.2.5.1.2 Germany Lymphoma Treatments Market by Treatment Drug
9.2.5.2 France Lymphoma Treatments Market
9.2.5.2.1 France Lymphoma Treatments Market by Treatment Type
9.2.5.2.2 France Lymphoma Treatments Market by Treatment Drug
9.2.5.3 Italy Lymphoma Treatments Market
9.2.5.3.1 Italy Lymphoma Treatments Market by Treatment Type
9.2.5.3.2 Italy Lymphoma Treatments Market by Treatment Drug
9.2.5.4 Spain Lymphoma Treatments Market
9.2.5.4.1 Spain Lymphoma Treatments Market by Treatment Type
9.2.5.4.2 Spain Lymphoma Treatments Market by Treatment Drug
9.2.5.5 United Kingdom Lymphoma Treatments Market
9.2.5.5.1 United Kingdom Lymphoma Treatments Market by Treatment Type
9.2.5.5.2 United Kingdom Lymphoma Treatments Market by Treatment Drug
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Lymphoma Treatments Market Overview
9.3.2 Asia-Pacific Lymphoma Treatments Market Forecasts and Analysis
9.3.3 Asia-Pacific Lymphoma Treatments Market Forecasts and Analysis - By Treatment Type
9.3.4 Asia-Pacific Lymphoma Treatments Market Forecasts and Analysis - By Treatment Drug
9.3.5 Asia-Pacific Lymphoma Treatments Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Lymphoma Treatments Market
9.3.5.1.1 Australia Lymphoma Treatments Market by Treatment Type
9.3.5.1.2 Australia Lymphoma Treatments Market by Treatment Drug
9.3.5.2 China Lymphoma Treatments Market
9.3.5.2.1 China Lymphoma Treatments Market by Treatment Type
9.3.5.2.2 China Lymphoma Treatments Market by Treatment Drug
9.3.5.3 India Lymphoma Treatments Market
9.3.5.3.1 India Lymphoma Treatments Market by Treatment Type
9.3.5.3.2 India Lymphoma Treatments Market by Treatment Drug
9.3.5.4 Japan Lymphoma Treatments Market
9.3.5.4.1 Japan Lymphoma Treatments Market by Treatment Type
9.3.5.4.2 Japan Lymphoma Treatments Market by Treatment Drug
9.3.5.5 South Korea Lymphoma Treatments Market
9.3.5.5.1 South Korea Lymphoma Treatments Market by Treatment Type
9.3.5.5.2 South Korea Lymphoma Treatments Market by Treatment Drug
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Lymphoma Treatments Market Overview
9.4.2 Middle East and Africa Lymphoma Treatments Market Forecasts and Analysis
9.4.3 Middle East and Africa Lymphoma Treatments Market Forecasts and Analysis - By Treatment Type
9.4.4 Middle East and Africa Lymphoma Treatments Market Forecasts and Analysis - By Treatment Drug
9.4.5 Middle East and Africa Lymphoma Treatments Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Lymphoma Treatments Market
9.4.5.1.1 South Africa Lymphoma Treatments Market by Treatment Type
9.4.5.1.2 South Africa Lymphoma Treatments Market by Treatment Drug
9.4.5.2 Saudi Arabia Lymphoma Treatments Market
9.4.5.2.1 Saudi Arabia Lymphoma Treatments Market by Treatment Type
9.4.5.2.2 Saudi Arabia Lymphoma Treatments Market by Treatment Drug
9.4.5.3 U.A.E Lymphoma Treatments Market
9.4.5.3.1 U.A.E Lymphoma Treatments Market by Treatment Type
9.4.5.3.2 U.A.E Lymphoma Treatments Market by Treatment Drug
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Lymphoma Treatments Market Overview
9.5.2 South and Central America Lymphoma Treatments Market Forecasts and Analysis
9.5.3 South and Central America Lymphoma Treatments Market Forecasts and Analysis - By Treatment Type
9.5.4 South and Central America Lymphoma Treatments Market Forecasts and Analysis - By Treatment Drug
9.5.5 South and Central America Lymphoma Treatments Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Lymphoma Treatments Market
9.5.5.1.1 Brazil Lymphoma Treatments Market by Treatment Type
9.5.5.1.2 Brazil Lymphoma Treatments Market by Treatment Drug
9.5.5.2 Argentina Lymphoma Treatments Market
9.5.5.2.1 Argentina Lymphoma Treatments Market by Treatment Type
9.5.5.2.2 Argentina Lymphoma Treatments Market by Treatment Drug
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. LYMPHOMA TREATMENTS MARKET, KEY COMPANY PROFILES
11.1. ABBOTT LABORATORIES
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ABIOGEN PHARMA S.P.A.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. AETERNA ZENTARIS, INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. BRISTOL-MYERS SQUIBB COMPANY,
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. CELGENE CORPORATION
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. ELI LILLY AND COMPANY
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. F. HOFFMANN-LA ROCHE LTD.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. JOHNSON AND JOHNSON
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. MERCK AND CO., INC.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. SEATTLE GENETICS, INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott Laboratories
2. ABIOGEN PHARMA S.p.A.
3. Aeterna Zentaris, Inc.
4. Bristol-Myers Squibb Company,
5. Celgene Corporation
6. Eli Lilly and Company
7. F. Hoffmann-La Roche Ltd.
8. Johnson & Johnson
9. Merck & Co., Inc.
10. Seattle Genetics, Inc.
TIPRE00010490
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.